Prevention of arthritis and arthrosis in children.Why are osteobiotics needed after antibiotics?-Reference-Cited by-同舟云学术

Prevention of arthritis and arthrosis in children.Why are osteobiotics needed after antibiotics?

Published:2024-02-18 Issue:2 Volume: Page:48-61
ISSN:2075-0277
Container-title:Terapevt (General Physician)
language:
Short-container-title:General Physician

Author:

,Sergeeva-Kondrachenko M. Yu.,Musatova L. A., ,Alekseeva N. Yu., ,Radchenko L. G., ,Elistratov D. G., ,Poluboyarinov P. A., ,Gorina O. S., ,Pronkina A. A., ,Burmistrova S. S.,

Abstract

Among the numerous side effects of antibiotic therapy, disorders in the work of the osteoarticular system occupy a separate and insufficiently studied niche. The article examines the effect of antibiotics on bone and cartilage tissue in children. A method for the prevention and therapy of drug-induced osteoarticular pathologies by means of a new group of drugs, osteobiotics, is proposed.

Publisher

PANORAMA Publishing House

Reference33 articles.

1. 1. Shamna M., Dilip C., Ajmal M. et al. A prospective study on adverse drug reactions of antibiotics in a tertiary care hospital // Saudi Pharm. J. 2013; 1: 6.

2. 2. Baranov A.A. et al. Primenenie antibiotikov u detei v ambulatornoi praktike. Prakticheskie rekomendatsii [The use of antibiotics in children in outpatient practice. Practical recommendations] // Klin. mikrobiol. antimikrob. khimioter. [Clinical Microbiology and Antimicrobial Chemotherapy]. 2007; 3 (9): 200-210. (In Russ.)

3. 3. Pikuza O. I., Samorodnova E.A. Tenevye storony antibiotikoterapii u detei: o chem dolzhen pomnit pediatr [The shadow sides of antibiotic therapy in children: what a pediatrician should remember] // Prakticheskaia meditsina [Practical Medicine]. 2018; 8 (16): 50-55. (In Russ.)

4. 4. Akimkin V.G., Tutelian A.V., Shulakova N. I., Voronin E.M. Pandemiia COVID-19: novyi vitok narastaniia antibiotikorezistentnosti [COVID-19 pandemic: a new round of antibiotic resistance] // Infektsionnye bolezni [Infectious Diseases]. 2021; 19 (3): 133-138. DOI: 10.2 0953/1729-9225-2021-3-133-138. (In Russ.)

5. 5. Yin X., Liu L., Xu X. et al. Evaluation of early antibiotics use in non-severe COVID-19 patients admitted with low risk of bacterial infection // Int.J. Antimicrob. Agents. 2022; 59 (1): 106462. DOI: 10.1016/j.ijantimicag.2021.106462